Rivaroxabanum

Rivaroxabanum est factoris Xa inhibitor atque substantia anticoagulans in thrombosibus venosis tractandis. Usus additus embolismorum pulmonum sive providentiae apoplexiae cerebri est^[1].

Cave: notitiae huius paginae nec praescriptiones nec consilia medica sunt.

Rivaroxabanum


Natura pharmacologia
Tempus semivitae biologicum: 5 — 9 h

Natura Rivaroxabani

Natura chemica

Rivaroxabanum oxazolidonorum est. Nomen chemicum est (S)-5-chloro-N-{2-oxo-3-[4-(3-oxomorpholin-4-yl)phenyl]-1,3-oxazolidin-5-ylmethyl]-thiopheno-2-carbamidum.

Rivaroxabanum est substratum cytochromatis CYP3A4^[2]. Massa molaris est 435.88 g/mol.

Nexus interni

Notae

↑ Camm AJ, Lip GYH, De Caterina R et al. (2012). "2012 focused update of the ESC Guidelines for the management of atrial fibrillation: An update of the 2010 ESC Guidelines for the management of atrial fibrillation". Eur Heart J 33: 2719-47
↑ Apixabani interactionum effectus (Anglice)

[1] Camm AJ, Lip GYH, De Caterina R et al. (2012). "2012 focused update of the ESC Guidelines for the management of atrial fibrillation: An update of the 2010 ESC Guidelines for the management of atrial fibrillation". Eur Heart J 33: 2719-47

[UW_API-2] Apixabani interactionum effectus (Anglice)

[1]

[2]